DK3654973T3 - Sammensætninger mod candida-infektioner - Google Patents

Sammensætninger mod candida-infektioner Download PDF

Info

Publication number
DK3654973T3
DK3654973T3 DK18745504.3T DK18745504T DK3654973T3 DK 3654973 T3 DK3654973 T3 DK 3654973T3 DK 18745504 T DK18745504 T DK 18745504T DK 3654973 T3 DK3654973 T3 DK 3654973T3
Authority
DK
Denmark
Prior art keywords
compositions against
against candida
candida infections
infections
compositions
Prior art date
Application number
DK18745504.3T
Other languages
English (en)
Inventor
Bruno Cammue
Karin Thevissen
Cremer Kaat De
Paul Cos
Original Assignee
Univ Leuven Kath
Univ Antwerpen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1711512.2A external-priority patent/GB201711512D0/en
Application filed by Univ Leuven Kath, Univ Antwerpen filed Critical Univ Leuven Kath
Application granted granted Critical
Publication of DK3654973T3 publication Critical patent/DK3654973T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK18745504.3T 2017-07-18 2018-07-05 Sammensætninger mod candida-infektioner DK3654973T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1711512.2A GB201711512D0 (en) 2017-07-18 2017-07-18 Compositions against candida infections
LU100445 2017-09-20
PCT/EP2018/068192 WO2019015975A1 (en) 2017-07-18 2018-07-05 COMPOSITIONS AGAINST CANDIDA INFECTIONS

Publications (1)

Publication Number Publication Date
DK3654973T3 true DK3654973T3 (da) 2021-11-15

Family

ID=63012980

Family Applications (1)

Application Number Title Priority Date Filing Date
DK18745504.3T DK3654973T3 (da) 2017-07-18 2018-07-05 Sammensætninger mod candida-infektioner

Country Status (13)

Country Link
US (2) US11793790B2 (da)
EP (2) EP3654973B1 (da)
CY (1) CY1125444T1 (da)
DK (1) DK3654973T3 (da)
ES (2) ES2960745T3 (da)
HR (1) HRP20211731T1 (da)
HU (1) HUE056271T2 (da)
LT (1) LT3654973T (da)
PL (2) PL3654973T3 (da)
PT (1) PT3654973T (da)
RS (1) RS62502B1 (da)
SI (1) SI3654973T1 (da)
WO (1) WO2019015975A1 (da)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU513753B2 (en) * 1974-07-08 1980-12-18 Johnson & Johnson Antimicrobial composition
DE3682908D1 (de) * 1985-09-24 1992-01-23 Ss Pharmaceutical Co Fungizides mittel.
WO1996040121A1 (fr) * 1995-06-07 1996-12-19 Taisho Pharmaceutical Co., Ltd. Agent antifongique
US7868162B2 (en) * 1998-12-30 2011-01-11 Lakewood-Amedex, Inc. Antimicrobial and antiviral compounds and methods for their use
IL143477A (en) * 2001-05-31 2009-07-20 Finetech Pharmaceutical Ltd Process for the preparation of 17-phenyl-18,19,20-trinor-pgf2?? and its derivatives
AU2002228760A1 (en) * 2000-10-26 2002-05-06 Merck & Co., Inc. Mammalian metabolites of a tachykinin receptor antagonist
WO2015102850A2 (en) * 2014-01-02 2015-07-09 Cook Medical Technologies Llc Compositions, devices and methods for treating infections
US9782333B2 (en) * 2015-01-21 2017-10-10 Chattem Inc. Oral composition for xerostomia

Also Published As

Publication number Publication date
SI3654973T1 (sl) 2021-12-31
EP3949962C0 (en) 2023-09-13
US20200138786A1 (en) 2020-05-07
ES2895653T3 (es) 2022-02-22
PL3654973T3 (pl) 2022-01-17
CY1125444T1 (el) 2023-03-24
HUE056271T2 (hu) 2022-02-28
EP3949962A1 (en) 2022-02-09
WO2019015975A1 (en) 2019-01-24
EP3654973B1 (en) 2021-08-18
EP3949962B1 (en) 2023-09-13
PT3654973T (pt) 2021-10-15
EP3654973A1 (en) 2020-05-27
PL3949962T3 (pl) 2024-03-18
ES2960745T3 (es) 2024-03-06
LT3654973T (lt) 2021-11-25
HRP20211731T1 (hr) 2022-02-18
US20230414570A1 (en) 2023-12-28
US11793790B2 (en) 2023-10-24
RS62502B1 (sr) 2021-11-30

Similar Documents

Publication Publication Date Title
DK3688162T3 (da) Formuleringer
DK3804737T3 (da) Sammensætninger omfattende bakteriestammer
DK3697376T3 (da) Sammensætning
MA49519A (fr) Compositions agricoles
MA52546A (fr) Compositions ciblées
DK3416996T3 (da) Hærdelig sammensætning
MA50657A (fr) Formulations de niraparib
DK3250182T3 (da) Dispergible sammensætninger
DK3334726T3 (da) Plinabulinsammensætninger
DK3600363T3 (da) Sammensætninger omfattende bakteriestammer
DK3528902T3 (da) Ringegelsammensætning
DK3451829T3 (da) Antimikrobielle sammensætninger
DK3638271T3 (da) Sammensætninger omfattende bakteriestammer
MA50787A (fr) Compositions fongicides
DK3583943T3 (da) Farmaceutisk sammensætning
MA50068A (fr) Formulations de copanlisib
DK3316857T3 (da) Multifasiske sammensætninger
DK3418355T3 (da) Skyllemiddelsaktive sammensætninger
DK3840596T3 (da) Sammensætning
DK3609464T3 (da) Xanthohumolbaserede sammensætninger
DK3528791T3 (da) Dispergible sammensætninger
DK3416502T3 (da) Glykæmisk-reducerende sammensætning
ES1209313Y (es) Composicion liofilizada
DK3706724T3 (da) Orale rifamycin-sv-sammensætninger
DK3470482T3 (da) Coatingsammensætning